Amendment 1 RFP 75N93023R00012.pdf
PDF 140 KB Posted
- Solicitation number
- 75N93023R00012
About this file
This amendment to a request for proposals provides clarification on technical cost assumptions and responses to questions from potential offerors. The amendment modifies item e under Technical Cost Assumptions in Attachment 5 to state that offerors should assume 500 ADCC assays and 200 ADCP assays annually rather than the incorrectly stated 5,000 and 200. It also clarifies that offerors may not deviate from the required full-time equivalents listed in the original RFP. The question and response portion addresses an inquiry regarding budgeting for a higher level of full-time equivalents than specified to account for the incorrectly stated 5,000 ADCC assays; offerors are advised this is not allowed and the RFP's FTE requirements must be followed. The amendment does not change the February 16, 2024 proposal submission deadline.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Amendment 2 RFP 75N93023R00012.pdf | ||
| 75N93023R00012 with Attachments.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
AMENDMENT #1 RFP No. 75N93023R00012 1
Amendment No. 1 RFP No. 75N93023R00012
“Nonhuman Primate Core Humoral Immunology Laboratory for AIDS Vaccine Research and Development”
Solicitation Number: 75N93023R00012
Amendment Number: One (1)
Amendment Issue Date: December 6, 2023
Proposal Due Date/Time: February 16, 2024 at 3:00 PM, EST (Unchanged)
Issued By: Christopher Ray
Contract Specialist
OA/DEA/NIAID/NIH/DHHS
5601 Fishers Lane, Room 3D10, MSC 9821 Bethesda, Maryland 20892-9821
Points of Contact: PRIMARY chris.ray@nih.gov Chris Ray, Contract Specialist Phone: 240.627.3365
SECONDARY
cornorj@niaid.nih.gov Robert Corno, Contracting Officer Phone: 240.669.5151
Please note that we do NOT intend to extend the due date for submission of proposals as a result of this amendment. The date specified for receipt of proposals remains unchanged.
Offerors must acknowledge receipt of this Amendment by identifying the amendment number and the date of the amendment on each copy of the submitted proposal. Failure to receive your acknowledgement may result in the rejection of your proposal. Except as provided herein, all terms and conditions of the solicitation remain unchanged and in full force and effect.
The purpose of this Amendment is to provide responses to questions from potential offerors, regarding the solicitation.
RESPONSES TO QUESTIONS FROM POTENTIAL OFFERORS:
mailto:chris.ray@nih.gov mailto:cornorj@niaid.nih.gov
AMENDMENT #1 RFP No. 75N93023R00012 2
Question 1 Per Attachment 5: Additional Business Proposal Instructions and Uniform Cost Assumptions, Section 3, Uniform Cost Assumptions, paragraph 2, Technical Cost Assumptions, item e. states that the contractor is to assume 5,000 ADCC assays and 200 ADCP assays.
To budget for 5000 ADCC assays per year, the total FTEs for the contract will exceed the expected FTEs by a large margin. Would it be acceptable if our budget includes much higher level of FTEs than listed in the RFP to ensure our capacity for 5000 ADCC assays per year?
Please advise.
Response to Question 1 This is an error in the Technical Cost Assumptions. Item e. should read as follows:
e. 500 ADCC assays and 200 ADCP assays.
Also, just to clarify, an offeror is not allowed to deviate from the required FTEs listed in the RFP.
END OF AMENDMENT NO. 1, RFP No. 75N93023R00012
File details come from the government source that posted it. Updated .